RU2000119110A - CHROMAN DERIVATIVES SUBSTITUTED BY CARBOXYL GROUP APPLICABLE AS BETA-3-ADRENERECEPTOR AGONISTS - Google Patents
CHROMAN DERIVATIVES SUBSTITUTED BY CARBOXYL GROUP APPLICABLE AS BETA-3-ADRENERECEPTOR AGONISTSInfo
- Publication number
- RU2000119110A RU2000119110A RU2000119110/04A RU2000119110A RU2000119110A RU 2000119110 A RU2000119110 A RU 2000119110A RU 2000119110/04 A RU2000119110/04 A RU 2000119110/04A RU 2000119110 A RU2000119110 A RU 2000119110A RU 2000119110 A RU2000119110 A RU 2000119110A
- Authority
- RU
- Russia
- Prior art keywords
- carbon atoms
- group
- compound according
- alkyl
- phenyl
- Prior art date
Links
- -1 CARBOXYL GROUP Chemical group 0.000 title claims 3
- VZWXIQHBIQLMPN-UHFFFAOYSA-N Chromane Chemical group C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title claims 3
- 239000000556 agonist Substances 0.000 title 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 150000004820 halides Chemical class 0.000 claims 4
- 125000005842 heteroatoms Chemical group 0.000 claims 4
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 4
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 4
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 4
- 125000004434 sulfur atoms Chemical group 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 102100014184 ADRB3 Human genes 0.000 claims 1
- 101700073744 ADRB3 Proteins 0.000 claims 1
- 230000001270 agonistic Effects 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Claims (14)
где R означает водород, гидроксильную, оксо-, галогенидную, галогенидалкильную с 1-10 атомами углерода, алкильную с 1-10 атомами углерода, нитрильную, нитро-, NR1R1, SR1, OR1, SO2R2, OCOR2, NR1COR2, COR2, NR1SO2R2, NR1CO2R1, алкоксильную с 1-10 атомами углерода, фенильную, пиррольную группу или 5- или 6-членное гетероциклическое кольцо, содержащее от 1 до 4 гетероатомов, выбранных из группы, включающей атомы О, S и N, и каждый фрагмент может содержать в качестве заместителей гидроксильную, галогенидную, нитрильную, NR1R1, SR1, трифторметильную, OR1, циклоалкильную с 3-8 атомами углерода, фенильную, NR1COR2, COR2, SO2R2, OCOR2, NR1SO2R2, NR1CO2R1, алкильную с 1-10 атомами углерода, алкоксильную с 1-10 атомами углерода и OR группу и каждый циклический фрагмент может быть сконденсирован с 5-членным гетероциклическим кольцом, содержащим 1 - 4 гетероатомов, выбранных из группы, включающей атомы О, S и N, и конденсированное гетероциклическое кольцо также может быть сконденсировано с фенильным кольцом или может содержать оксогруппу в качестве заместителя;
R1 означает водород, алкильную группу с 1-10 атомами углерода, необязательно замещенную от 1 до 4 заместителями, выбранными из группы, включающей гидроксильную, галогенидную, СО2Н, СО2-алкильную с 1-10 атомами углерода, SО2-алкильную с 1-10 атомами углерода, алкоксильную с 1-10 атомами углерода группу; или циклоалкильную с 3-8 атомами углерода, фенильную или нафтильную группу, каждая из которых может содержать 1 - 4 заместителей, выбранных из группы, включающей галогенидную, нитро-, оксо-, алкильную с 1-10 атомами углерода, алкоксильную с 1-10 атомами углерода, тиоалкильную с 1-10 атомами углерода;
R2 означает R1 или NR1R1;
R3 означает водород, алкильную группу с 1-10 атомами углерода, CO2R1 или
Аr1 означает фенильную группу или 5- или 6-членное гетероциклическое кольцо, содержащее от 1 до 4 гетероатомов, выбранных из группы, включающей атомы О, S и N, и каждый фрагмент может быть сконденсирован с 5-членным гетероциклическим кольцом, содержащим от 1 до 4 гетероатомов, выбранных из группы, включающей атомы О, S и N, и конденсированное гетероциклическое кольцо также может быть сконденсировано с фенильным кольцом или может содержать оксогруппу в качестве заместителя;
m равно 1,2 или 3;
n в каждом случае независимо равно 0,1 или 2;
X означает алкильную группу с 1-4 атомами углерода, необязательно замещенную
галогеном;
R4 означает гидроксильную, алкоксильную группу с 1-10 атомами углерода, O-R1 или NR1R1,
и приемлемые с фармацевтической точки зрения его соли или сложные эфиры.1. The compound of the formula
where R means hydrogen, hydroxyl, oxo-, halide, halide alkyl with 1-10 carbon atoms, alkyl with 1-10 carbon atoms, nitrile, nitro, NR 1 R 1 , SR 1 , OR 1 , SO 2 R 2 , OCOR 2 , NR 1 COR 2 , COR 2 , NR 1 SO 2 R 2 , NR 1 CO 2 R 1 , alkoxy with 1-10 carbon atoms, a phenyl, pyrrole group or a 5- or 6-membered heterocyclic ring containing from 1 to 4 heteroatoms selected from the group comprising O, S, and N atoms, and each fragment may contain hydroxyl, halide, nitrile, NR 1 R 1 , SR 1 , trifluoromethyl, OR 1 , cycloalkyl with 3 as substituents -8 carbon atoms, phenyl, NR 1 COR 2 , COR 2 , SO 2 R 2 , OCOR 2 , NR 1 SO 2 R 2 , NR 1 CO 2 R 1 , alkyl with 1-10 carbon atoms, alkoxy with 1-10 carbon atoms and the OR group and each cyclic moiety may be condensed with a 5-membered heterocyclic ring containing 1 to 4 heteroatoms selected from the group comprising O, S, and N atoms, and the fused heterocyclic ring may also be condensed with a phenyl ring or contain an oxo group as a substituent;
R 1 means hydrogen, an alkyl group with 1-10 carbon atoms, optionally substituted with 1 to 4 substituents selected from the group consisting of hydroxyl, halide, CO 2 H, CO 2 alkyl with 1-10 carbon atoms, SO 2 alkyl with 1-10 carbon atoms, alkoxy with 1-10 carbon atoms group; or cycloalkyl with 3-8 carbon atoms, a phenyl or naphthyl group, each of which may contain 1 to 4 substituents selected from the group including halide, nitro, oxo, alkyl with 1-10 carbon atoms, alkoxy with 1-10 thioalkyl carbon atoms with 1-10 carbon atoms;
R 2 is R 1 or NR 1 R 1 ;
R 3 means hydrogen, an alkyl group with 1-10 carbon atoms, CO 2 R 1 or
Ar 1 means a phenyl group or a 5- or 6-membered heterocyclic ring containing from 1 to 4 heteroatoms selected from the group comprising O, S and N atoms, and each fragment can be condensed with a 5-membered heterocyclic ring containing from 1 up to 4 heteroatoms selected from the group consisting of O, S and N atoms, and a fused heterocyclic ring may also be condensed with a phenyl ring or may contain an oxo group as a substituent;
m is 1.2 or 3;
n in each case is independently 0.1 or 2;
X means an alkyl group with 1-4 carbon atoms, optionally substituted
halogen;
R 4 means a hydroxyl, alkoxy group with 1-10 carbon atoms, OR 1 or NR 1 R 1 ,
and pharmaceutically acceptable salts or esters thereof.
где R3 означает водород, алкильную группу с 1-10 атомами углерода, CO2R1 или
m равно 1, 2 или З;
n в каждом случае независимо равно 0,1 или 2;
R4 означает гидроксильную, O-R1, алкоксильную группу с 1-10 атомами углерода или NR1R1.6. Used to obtain the compounds of formula I, the compound of the formula
where R 3 means hydrogen, an alkyl group with 1-10 carbon atoms, CO 2 R 1 or
m is 1, 2 or 3;
n in each case is independently 0.1 or 2;
R 4 means hydroxyl, OR 1 , CNS group with 1-10 carbon atoms or NR 1 R 1 .
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99462097A | 1997-12-19 | 1997-12-19 | |
US08/994,620 | 1997-12-19 | ||
US08/994620 | 1997-12-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000119110A true RU2000119110A (en) | 2002-09-27 |
RU2223269C2 RU2223269C2 (en) | 2004-02-10 |
Family
ID=25540853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000119110/04A RU2223269C2 (en) | 1997-12-19 | 1998-12-16 | Derivatives of chroman, intermediate compounds, pharmaceutical composition and method for treatment |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1040106B1 (en) |
JP (1) | JP2001526282A (en) |
KR (1) | KR20010033188A (en) |
CN (1) | CN1284952A (en) |
AT (1) | ATE222901T1 (en) |
AU (1) | AU749097B2 (en) |
BG (1) | BG104593A (en) |
BR (1) | BR9814302A (en) |
CA (1) | CA2316971A1 (en) |
DE (1) | DE69807523T2 (en) |
DK (1) | DK1040106T3 (en) |
ES (1) | ES2183434T3 (en) |
HU (1) | HUP0004565A3 (en) |
ID (1) | ID26524A (en) |
IL (1) | IL136689A0 (en) |
NO (1) | NO20003083L (en) |
NZ (1) | NZ505200A (en) |
PL (1) | PL341229A1 (en) |
PT (1) | PT1040106E (en) |
RU (1) | RU2223269C2 (en) |
SK (1) | SK9362000A3 (en) |
TR (1) | TR200001927T2 (en) |
UA (1) | UA62993C2 (en) |
WO (1) | WO1999032476A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035605A1 (en) | 2000-12-11 | 2004-06-16 | Bayer Corp | DERIVATIVES OF AMINOMETIL CHROMANO DI-SUBSTITUTES, A METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF USEFUL MEDICINES AS BETA-3-ADRENE-RECEPTORS AGONISTS |
AR035858A1 (en) * | 2001-04-23 | 2004-07-21 | Bayer Corp | CHROME DERIVATIVES 2,6-SUBSTITUTES, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF USEFUL MEDICINES AS BETA-3 ADRENORRECEPTING AGONISTS |
US20040265991A1 (en) * | 2001-10-17 | 2004-12-30 | Naoaki Taoka | Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
AR052674A1 (en) | 2005-02-17 | 2007-03-28 | Wyeth Corp | DERIVATIVES OF INDOL, BENZOTIOFEN, BENZOFURAN AND INDENO CICLOALQUILCONDENSADOS |
US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
ES2534318B1 (en) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Alkoxide substituted chromene derivatives as inhibitors of the TCR-Nck interaction |
ES2534336B1 (en) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Chromene derivatives as inhibitors of the TCR-Nck interaction |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
GB8801306D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
NZ265692A (en) * | 1993-06-14 | 1997-02-24 | Pfizer | Indole- and benzofuran- containing hydroxyamines and analogs; pharmaceutical compositions |
GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
-
1998
- 1998-12-16 SK SK936-2000A patent/SK9362000A3/en unknown
- 1998-12-16 ES ES98963240T patent/ES2183434T3/en not_active Expired - Lifetime
- 1998-12-16 ID IDW20001393A patent/ID26524A/en unknown
- 1998-12-16 NZ NZ505200A patent/NZ505200A/en unknown
- 1998-12-16 JP JP2000525413A patent/JP2001526282A/en not_active Withdrawn
- 1998-12-16 WO PCT/US1998/026735 patent/WO1999032476A1/en not_active Application Discontinuation
- 1998-12-16 PT PT98963240T patent/PT1040106E/en unknown
- 1998-12-16 UA UA2000074336A patent/UA62993C2/en unknown
- 1998-12-16 AU AU18300/99A patent/AU749097B2/en not_active Ceased
- 1998-12-16 HU HU0004565A patent/HUP0004565A3/en unknown
- 1998-12-16 TR TR2000/01927T patent/TR200001927T2/en unknown
- 1998-12-16 DK DK98963240T patent/DK1040106T3/en active
- 1998-12-16 IL IL13668998A patent/IL136689A0/en unknown
- 1998-12-16 AT AT98963240T patent/ATE222901T1/en not_active IP Right Cessation
- 1998-12-16 DE DE69807523T patent/DE69807523T2/en not_active Expired - Fee Related
- 1998-12-16 RU RU2000119110/04A patent/RU2223269C2/en not_active IP Right Cessation
- 1998-12-16 KR KR1020007006572A patent/KR20010033188A/en not_active Application Discontinuation
- 1998-12-16 CN CN98813619A patent/CN1284952A/en active Pending
- 1998-12-16 CA CA002316971A patent/CA2316971A1/en not_active Abandoned
- 1998-12-16 PL PL98341229A patent/PL341229A1/en not_active Application Discontinuation
- 1998-12-16 BR BR9814302-6A patent/BR9814302A/en not_active IP Right Cessation
- 1998-12-16 EP EP98963240A patent/EP1040106B1/en not_active Expired - Lifetime
-
2000
- 2000-06-15 NO NO20003083A patent/NO20003083L/en not_active Application Discontinuation
- 2000-07-11 BG BG104593A patent/BG104593A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2213089C2 (en) | Monocyclic benzamides of derivatives of 3- or 4-substituted 4-(aminomethyl)piperidine, methods for their preparing, pharmaceutical composition, method for its preparing, derivative of carboxylic acid | |
ATE63914T1 (en) | N6-DISUBSTITUTED PURINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND MEDICATIONS CONTAINING THESE COMPOUNDS. | |
KR950704330A (en) | Rapamycin carbonate esters as immunosuppressant agents | |
RU94006013A (en) | OXAZOLIDINDION DERIVATIVES, THEIR PRODUCTION AND APPLICATION | |
RU97119064A (en) | APPLICATION OF ALPHA (IL) AGONISTS FOR THE TREATMENT OF URINE HOLDING | |
RU92016545A (en) | HETEROCYCLIC COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION | |
RU95117068A (en) | ANTIHYPERTRIGLICYRIDEMIC COMPOSITION, METHOD FOR PRODUCING IT, METHOD FOR TREATING OR PREVENTION OF HYPERTRIGLYCERIDEMIA, USE OF COMPOUNDS | |
KR960702460A (en) | Thiazolidinedione and agents containing it (new THIAZOLIDINDIONES AND DRUGS CONTAINING THEM) | |
RU2000119110A (en) | CHROMAN DERIVATIVES SUBSTITUTED BY CARBOXYL GROUP APPLICABLE AS BETA-3-ADRENERECEPTOR AGONISTS | |
KR900015721A (en) | New Methods and Compounds | |
RU2000124402A (en) | DERIVATIVES OF AZETIDINE AND PYRROLIDINE | |
KR930004262A (en) | Metanoanthracene compounds | |
NO923126D0 (en) | PREPARATION AND METHOD OF CANCER TREATMENT | |
HU9202642D0 (en) | Method for producing piperidine derivatives and pharmaceutical preparatives containing said compounds as active substance | |
SE8006365L (en) | CYKLOHEXANKARBOXYLSYRADERIVAT | |
RU2223269C2 (en) | Derivatives of chroman, intermediate compounds, pharmaceutical composition and method for treatment | |
CS183791A3 (en) | Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and their therapeutical application | |
NO890440L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOKINOLINE DERIVATIVES. | |
RU2004134563A (en) | 2,5-DISPLACED 3-MERCAPTOPENTANIC ACID | |
ZA914801B (en) | Acylbenzoxazolines,process for preparing them and pharmaceutical compositions containing them | |
ES520868A0 (en) | A PROCEDURE FOR PREPARING SUBSTITUTED GUANIDINO-PHENYLAMIDINES. | |
TH8849EX (en) | 8-Substituted-2- New type of aminotetralene | |
KR910007875A (en) | Benzylpyrrolidine Derivatives As Dopamine Antagonists | |
RU93041059A (en) | 1-AZABITSIKLOALKAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, THEIR CONTAINING, AND METHOD OF THEIR OBTAINING | |
RU98109784A (en) | PHARMACEUTALLY ACTIVE QUINASOLINE DERIVATIVES |